跳至主要内容
临床试验/NCT03835416
NCT03835416已完成不适用

Enhanced Protein Intake During Obesity Reduction in Older Male Veterans: Differences in Physical Function and Muscle Quality Responses by Race

VA Office of Research and Development1 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2019年12月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
105
试验地点
1
主要终点
Total Short Physical Performance Battery (SPPB) Score at Baseline

研究概览

简要总结

Diabetes is a major health concern in obese older Veterans, especially in those who are African American. The negative impact of diabetes on muscle and physical function contributes to metabolic as well as physical decline and is under-studied. This randomized controlled trial compares a higher-protein, weight loss regimen previously shown to improve physical function to an Recommended Dietary Allowance (RDA) protein intervention in obese older male Veterans with pre-diabetes and functional limitations. Equal numbers of white and black male Veterans will be studied, filling gaps in the investigators' knowledge of differential responses by race as well as obesity interventions for men in general. The primary outcome is functional performance by Short Physical Performance Battery and secondary measures include muscle quantity and composition, glucose handling, lean body mass, recent falls and fear of falling, and quality of life measured at 0, 3 and 6 months. The goal of this research is to accelerate functional recovery and enhance independence in obese male Veterans, which is strongly aligned with the VA mission to "maximize the physical and social autonomy of Veterans".

详细描述

This study examines an evidence-based obesity intervention as a means of reducing the impact of prediabetes on muscle function in obese older men of white and black race. A total of 64 obese (BMI 30 kg/m2) male Veterans aged 55 + yrs, with mild to moderate functional impairments (Short Physical Performance Battery score of 4 to 11 units) and prediabetes, will be randomized to a higher-protein weight loss treatment (HP-WL) or an RDA-level protein control weight loss treatment (C-WL). All participants receive individualized calorie prescriptions calculated to achieve a weight loss of ~1-2 pounds per week and attend weekly group support sessions designed to enhance diet compliance with goal setting, self-monitoring, stress management, and daily diet journaling. They will also attend a weekly low impact, chair exercise class. HP-WL participants are provided a supply of chilled/frozen high-quality protein foods (lean meats, low fat dairy products) sufficient to give 30 g high quality protein for two of three meals daily to help assure diet compliance. C-WL participants are provided 1 serving per day of high quality protein to avoid unintentional bias. Treatment responses will be compared for the primary outcome of functional performance by Short Physical Performance Battery and important secondary measures, including muscle quantity and composition, glucose handling, lean body mass, recent falls and fear of falling, and quality of life at 0, 3 and 6 months. An exploratory aim examines potential mediators of racial differences in treatment responses and documents the most successful intervention strategies. This randomized controlled trial of a balanced, higher-protein diet during a metabolic challenge (caloric restriction) in those with prediabetes also considers racial differences in responses of obese older men to this regimen. Study findings will fulfill the RR&D mission by advancing interventions to improve physical function in older Veterans, yield novel information about the impact of balanced, higher protein on muscle and glucose handling, and explore racial differences in responses to obesity interventions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

盲法说明

Those responsible for outcomes assessment will be blinded from group treatment arm to every extent possible.

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •Male Veterans
  • •African American or Caucasian
  • •Obese (BMI > 30 kg/m2)
  • •Age 55+ years
  • •Pre-diabetes (confirmed fasting plasma glucose 100 and <126 mg/dL) or HbA1c 5.7-6.4%
  • •Short Physical Performance Battery score of 4 to 11 units
  • •Age-normal renal function
  • •English speaking
  • •Able to record dietary intake or has a proxy who can record dietary intake
  • •Willing and able to be randomized to either intervention group

排除标准

  • •Presence of unstable or symptomatic life-threatening illness
  • •Glomerular filtration rates (GFR) less than 45 mL/min
  • •A GFR of 45-59 requires bi-monthly testing per the investigators' established algorithm
  • •Those with a GFR <45 mL/min are excluded
  • •Mini Cog score of <3
  • •-Vegetarian
  • •Neurological conditions causing functional impairments, including:
  • •Parkinson's Disease
  • •multiple sclerosis
  • •permanent disability due to stroke
  • •Inability to complete physical function assessment
  • •History of significant weight instability
  • •Contraindicated medications, including narcotic mail-outs and active substance abuse
  • •Any psychiatric condition that would prevent the subject from participating in a group intervention setting, including diagnosed personality disorders
  • •Primary care provider disapproves participation

研究组 & 干预措施

WL-Control

Experimental

0.8 g protein per kg body weight. Seven servings of whey protein powder (15 g/serving) per week will be provided to participants to support diet affordability.

干预措施: Foods rich in high quality protein (Dietary Supplement)

WL-Protein

Experimental

>30 g of high quality protein per meal, 1.4 g protein/kg body weight/day. 21 servings of high quality (30 g/serving) protein (lean meats, whey protein powder, protein drinks) provided to participants each week to increase compliance.

干预措施: Foods rich in high quality protein (Dietary Supplement)

结局指标

主要结局

Total Short Physical Performance Battery (SPPB) Score at Baseline

时间窗: 0 months

SPPB total score is the sum of scores from 3 measures, namely balance, gait speed, and chair stands. Score scale 0-12. Higher numbers indicate higher functioning.

Change in Total Short Physical Performance Battery (SPPB) Score at 3 Months

时间窗: Baseline and 3 months

SPPB total score is the sum of scores from 3 measures, namely balance, gait speed, and chair stands. Score scale 0-12. Higher numbers indicate higher functioning. The change score is determined by the value at 3 months minus the value at baseline.

Change in Total Short Physical Performance Battery (SPPB) Score at 6 Months

时间窗: Baseline and 6 months

SPPB total score is the sum of scores from 3 measures, namely balance, gait speed, and chair stands. Score scale 0-12. Higher numbers indicate higher functioning. The change score is determined by the value at 6 months minus the value at baseline.

次要结局

  • Percent Change in Body Weight at 3 Months(Baseline and 3 months)
  • Percent Change in Body Weight at 6 Months(Baseline and 6 months)
  • Change in 6 Minute Walk Test (Aerobic Endurance) at 3 Months(Baseline and 3 months)
  • Change in 6 Minute Walk Test (Aerobic Endurance) at 6 Months(6 months)
  • Change in Timed 8-ft Up and Go (Agility/Dynamic Balance) at 3 Months(Baseline and 3 months)
  • Change in Timed 8-ft Up and Go (Agility/Dynamic Balance) at 6 Months(Baseline and 6 months)
  • Change in Number of Chair Stands in 30 Seconds (Lower Body Strength) at 3 Months(Baseline and 3 months)
  • Change in Number of Chair Stands in 30 Seconds (Lower Body Strength) at 6 Months(Baseline and 6 months)
  • Change in Isokinetic Knee Extension Peak Torque (Muscle Strength) at 3 Months(Baseline and 3 months)
  • Change in Isokinetic Knee Extension Peak Torque (Muscle Strength) at 6 Months(Baseline and 6 months)
  • Change in Isometric Hand Grip (Upper Body Strength) at 3 Months(Baseline and 3 months)
  • Change in Isometric Hand Grip (Upper Body Strength) at 6 Months(Baseline and 6 months)
  • Change in Minimal Waist Circumference at 3 Months(Baseline and 3 months)
  • Change in Minimal Waist Circumference at 6 Months(Baseline and 6 months)
  • Change in 3-day Diet Record, Protein, at 3 Months(Baseline and 3 months)
  • Change in Body Composition: Percent Lean Mass at 3 Months(Baseline and 3 months)
  • Change in Body Composition: Percent Lean Mass at 6 Months(Baseline and 6 months)
  • Change in Body Composition: Percent Fat Mass at 3 Months(Baseline and 3 months)
  • Change in Body Composition: Percent Fat Mass at 6 Months(Baseline and 6 months)
  • Percent Attendance at Weekly Diet Class Between Baseline and 6 Months(Baseline and 6 months)
  • Mini-Cog at Baseline Only(Baseline only)
  • Change in Computerized Axial Tomography (CAT) Scan at 3 Months(Baseline and 3 months)
  • Change in Computerized Axial Tomography (CAT) Scan at 6 Months(Baseline and 6 months)
  • Change in Short Form-36 (SF-36) Health Survey at 3 Months(Baseline and 3 months)
  • Change in Short Form-36 (SF-36) Health Survey at 6 Months(Baseline and 6 months)
  • Change in Profile of Mood States (POMS) at 3 Months(Baseline and 3 months)
  • Change in Profile of Mood States (POMS) at 6 Months(Baseline and 6 months)
  • Change in Center for Epidemiologic Studies Depression Scale (CES-D) at 3 Months(Baseline and 3 months)
  • Change in Center for Epidemiologic Studies Depression Scale (CES-D) at 6 Months(Baseline and 6 months)
  • Change in Perceived Stress Scale (PSS) at 3 Months(Baseline and 3 months)
  • Change in Perceived Stress Scale (PSS) at 6 Months(Baseline and 6 months)
  • Change in Pittsburgh Sleep Quality Index (PSQI) and 3 Months(Baseline and 3 months)
  • Change in Pittsburgh Sleep Quality Index (PSQI) and 6 Months(Baseline and 6 months)
  • Change in Satisfaction With Life Scale (SWLS) at 3 Months(Baseline and 3 months)
  • Change in Satisfaction With Life Scale (SWLS) at 6 Months(Baseline and 6 months)
  • Change in Hemoglobin A1c at 3 Months(Baseline and 3 months)
  • Change in Hemoglobin A1c at 6 Months(Baseline and 6 months)
  • Change in Fear of Falling at 3 Months(Baseline and 3 months)
  • Change in Fear of Falling at 6 Months(Baseline and 6 months)
  • Change in Number of Falls at 3 Months(Baseline and 3 months)
  • Change in Number of Falls at 6 Months(Baseline and 6 months)
  • Change in 3-day Diet Record, Calories, at 3 Months(Baseline and 3 months)
  • Change in 3-day Diet Record, Calories, at 6 Months(Baseline and 6 months)
  • Change in 3-day Diet Record, Protein, at 6 Months(Baseline and 6 months)
  • Number of Participants Measured Using an Axis Accelerometer (Actigraph)(6 months)
  • Change in Glucose Tolerance Test (OGTT) (78-80), Blood(6 months)
  • Percent Attendance at Weekly Diet Class Between Baseline and 3 Months(Baseline and 3 months)
  • Number of Participants Measured Using an Axis Accelerometer (Actigraph)(Baseline)
  • Number of Participants Measured Using an Axis Accelerometer (Actigraph)(3 months)
  • Change in Glucose Tolerance Test (OGTT) (78-80), Blood(3 months)

研究者

申办方类型
Fed
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验